Update regarding CEO - Peter Sargent

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce that Peter Sargent has agreed to extend his existing agreement with the Company and remain in his current role throughout June 2026.

The Board and Dr Sargent remain in ongoing discussions regarding a potentially longer-term continuation of his involvement, in relation to which further updates will be provided in due course.

The Board acknowledges Dr Sargent's professionalism and contribution during a period of considerable change within the business and looks forward to continuing what has become a productive working relationship.

Nick Tulloch, Chairman of Physiomics plc, commented: "In the short time we have worked with Pete, he has diligently overseen the operations of Physiomics and, in particular, has handled the management transition of the business with evident skill and sensitivity. Pete has been a considerable support to the new Board and we are delighted that he is willing to continue in his role for the time being whilst we develop plans for growth and expansion of the Company."

For more information about Physiomics and its services, please visit www.physiomics.co.uk.